| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 430 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200 |
| 2 | DEXAMETHASONE | 162 |
| 3 | DEXAMETHASONE 1.5 MG | 162 |
| 4 | ASPIRIN | 153 |
| 5 | ASPIRIN 325 MG | 148 |
| 6 | ASPIRIN 81 MG | 148 |
| 7 | ERGOCALCIFEROL | 143 |
| 8 | ACETAMINOPHEN | 126 |
| 9 | FUROSEMIDE | 122 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPARSENTAN | 80 | 0.0118 |
| 1 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 19 | 0.0069 |
| 2 | ERIBULIN MESYLATE | 20 | 0.0053 |
| 3 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 58 | 0.0051 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 18 | 0.0050 |
| 5 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 44 | 0.0049 |
| 6 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 49 | 0.0049 |
| 7 | ERGOCALCIFEROL | 143 | 0.0048 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 200 | 0.0044 |
| 9 | VOCLOSPORIN | 40 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thalidomide Analog [EPC] | 502 |
| 1 | Corticosteroid [EPC] | 364 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 298 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 261 |
| 4 | Benzodiazepine [EPC] | 174 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 155 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 149 |
| 7 | Provitamin D2 Compound [EPC] | 143 |
| 8 | Loop Diuretic [EPC] | 138 |
| 9 | Proteasome Inhibitor [EPC] | 137 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 5 | 0.0056 |
| 1 | Provitamin D2 Compound [EPC] | 143 | 0.0048 |
| 2 | Endoglycosidase [EPC] | 5 | 0.0027 |
| 3 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 9 | 0.0027 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 261 | 0.0024 |
| 5 | Pyruvate Kinase Activator [EPC] | 3 | 0.0023 |
| 6 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 13 | 0.0022 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 9 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |